Associate Editor
Dr. Sise is the Director of Onconephrology at Massachusetts General Hospital and an Associate Professor of Medicine at Harvard Medical School, Boston. She is a graduate of the University of Notre Dame, South Bend, IN, and Columbia University College of Physicians and Surgeons, New York, NY. Her research program focuses on improving the prevention, detection, and treatment of kidney injury that results from anticancer therapies.
Invivyd; Novartis
Alpine Immune Sciences/Vertex; Biogen; Curio; Infectious Diseases Society; Medibeacon; Medtelligence/Reach MD; Merida; Otsuka; Relay Tx; TD Cowen; Vera
Journal of Onconephrology; Kidney International Reports
Amgen; AstraZeneca; Cabaletta Bio; Gilead; Merck; Novartis; Otsuka; Roche/Genentech
American Society of Nephrology; National Kidney Foundation